Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Lymphocyte Migration Through Brain Endothelial Cell Monolayers Involves Signaling Through Endothelial ICAM-1 Via a Rho-Dependent Pathway

Peter Adamson, Sandrine Etienne, Pierre-Olivier Couraud, Virginia Calder and John Greenwood
J Immunol March 1, 1999, 162 (5) 2964-2973;
Peter Adamson
*Department of Clinical Ophthalmology, Institute of Ophthalmology, University College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandrine Etienne
†Laboratoire d’Immuno-Pharmacologie Moléculaire, Institut Cochin de Génétique Moléculaire, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre-Olivier Couraud
†Laboratoire d’Immuno-Pharmacologie Moléculaire, Institut Cochin de Génétique Moléculaire, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Calder
*Department of Clinical Ophthalmology, Institute of Ophthalmology, University College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Greenwood
*Department of Clinical Ophthalmology, Institute of Ophthalmology, University College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Lymphocyte extravasation into the brain is mediated largely by the Ig superfamily molecule ICAM-1. Several lines of evidence indicate that at the tight vascular barriers of the central nervous system (CNS), endothelial cell (EC) ICAM-1 not only acts as a docking molecule for circulating lymphocytes, but is also involved in transducing signals to the EC. In this paper, we examine the signaling pathways in brain EC following Ab ligation of endothelial ICAM-1, which mimics adhesion of lymphocytes to CNS endothelia. ICAM-1 cross-linking results in a reorganization of the endothelial actin cytoskeleton to form stress fibers and activation of the small guanosine triphosphate (GTP)-binding protein Rho. ICAM-1-stimulated tyrosine phosphorylation of the actin-associated molecule cortactin and ICAM-1-mediated, Ag/IL-2-stimulated T lymphocyte migration through EC monolayers were inhibited following pretreatment of EC with cytochalasin D. Pretreatment of EC with C3 transferase, a specific inhibitor of Rho proteins, significantly inhibited the transmonolayer migration of T lymphocytes, endothelial Rho-GTP loading, and endothelial actin reorganization, without affecting either lymphocyte adhesion to EC or cortactin phosphorylation. These data show that brain vascular EC are actively involved in facilitating T lymphocyte migration through the tight blood-brain barrier of the CNS and that this process involves ICAM-1-stimulated rearrangement of the endothelial actin cytoskeleton and functional EC Rho proteins.

To fulfill their role in tissue surveillance, lymphocytes must be able to leave the circulation and traffic through the solid tissues of the body. Thus, the migration of lymphocytes across the vascular endothelial cell (EC)3 wall is a prerequisite in the implementation of lymphocyte function. Lymphocyte transendothelial migration is dependent on lymphocyte activation via signaling through the T cell and IL-2 receptor 1 . The in vivo correlate of these observations is that only Ag-specfic, IL-2-dependent T cells are capable of trafficking to the central nervous system (CNS) 2 . The vascular recruitment of circulating lymphocytes and their transvascular migration has been the subject of substantial investigation and has led to a greater understanding of the role of lymphocytes under normal and inflammatory conditions. Unlike most vascular endothelia, which are connected together by incomplete, permeable junctions, those of the brain and retina are joined together by impermeable tight junctions forming the blood-brain and inner blood-retinal barriers, respectively. Despite these barriers, a low level of leukocyte traffic into the CNS occurs 2 , and this can be dramatically up-regulated during the development of immune-mediated diseases. To achieve entry, lymphocytes must either penetrate the tight junctions or migrate through the body of the CNS EC through the formation of pores. Whichever path is utilized during leukocyte diapedesis within the CNS, it is highly likely that this process can only operate with the active participation of the EC. Although it is clear that the activation state of lymphocytes is central in controlling transvascular migration 1, 3, 4 , additional control may be provided by the CNS endothelia to further facilitate the passage of migratory cells across the impermeable vessel wall.

The mechanisms by which vascular EC capture circulating lymphocytes are now well characterized and many of the ligands that contribute to their adhesion and subsequent transvascular migration identified 5, 6 . Previous studies have shown that initial capture of immune cells from the circulation occurs via endothelial selectin molecules that result in weak attachment and, under conditions of flow, result in leukocyte rolling along the vessel wall 6 . Tighter binding and subsequent migration through the EC wall is mediated predominantly by the LFA-1/ICAM-1 (and possibly ICAM-2) pairing. However, on cytokine-activated endothelia, both the LFA-1/ICAM-1 and the very late Ag-4/VCAM-1 interaction appear to play a part in T lymphocyte migration 3, 7, 8, 9 . Recent studies indicate that the molecules employed during lymphocyte adhesion to and migration through CNS endothelium are essentially the same as those governing recruitment at other vascular beds, with ICAM-1 being the predominant endothelial molecule involved in migration 1, 10, 11 . However, the active participation of CNS EC in leukocyte extravasation, above that of the provision of adhesion molecules, has remained largely speculative.

If CNS endothelia play an active part in facilitating lymphocyte diapedesis, it is likely that they receive external signals from adherent lymphocytes. This has led to the possibility that molecules intimately involved in lymphocyte diapedesis, such as EC ICAM-1, may also be involved in the transduction of extracellular signals. Proteins of the Ig superfamily, including CD2, CD4, MHC molecules and Fcγ are well-documented as signal transducers in both lymphocytes 12 and U937 cells 13 . In addition, neural cell adhesion molecule has also been shown to be capable of signal transduction in PC12 cells 14 . Although it has been demonstrated in leukocytes that ICAM-1 is capable of generating intracellular signals 15, 16, 17 , and more recently, signaling via VCAM-1 and platelet endothelial call adhesion molecule-1 has been demonstrated in platelets 18 and EC 19 , the functional effects of signaling via Ig superfamily molecules in EC remain unresolved.

Studies aimed at exploring the signal transduction pathways in CNS EC that may lead to lymphocyte extravasation have been greatly expedited by the recent development of two immortalized Lewis rat brain microvessel EC lines that have been immortalized with the E1A adenovirus protein (RBE4 cell line; 20, 21) and SV40 large T Ag (GP8.3 cell line; 22) and that retain in culture the differentiated phenotype of brain endothelia. Previous studies with RBE4 cells have shown that Ab cross-linking of endothelial ICAM-1 molecules (used to mimic lymphocyte binding to EC via LFA-1) or coculture of EC with lymphocytes triggers p60src activity, which appears to be responsible for the enhanced tyrosine phosphorylation of the actin-binding protein cortactin 20 . The enhanced tyrosine phosphorylation of cortactin following cross-linking of EC with ICAM-1 or coculture with encephalitogenic T lymphocytes was the first indication of an active endothelial involvement in controlling transvascular lymphocyte migration following T cell binding. Furthermore, it also served to demonstrate that T lymphocyte binding can be mimicked by ligation of EC ICAM-1. However, more recently, additional actin cytoskeletal-associated proteins, such as focal adhesion kinase (FAK), paxillin, and p130cas, have also been shown to be tyrosine phosphorylated in response to ICAM-1 cross-linking 23 . In this paper, we have further extended this work and present evidence for the first time that CNS vascular EC are intimately involved in the processes controlling the transendothelial migration of T lymphocytes across cultures of rat brain endothelial monolayers. These processes require an ICAM-1-stimulated rearrangement of the endothelial actin cytoskeleton and functional endothelial Rho proteins.

Materials and Methods

Materials

[α-32P]Nicotinamide adenine dinucleotide (NAD) was obtained from New England Nuclear (Herts, U.K.). Na[51Cr207], [32P]orthophosphate, peroxidase coupled rabbit anti-mouse (RAM) IgG, and enhanced chemiluminescence (ECL) reagents were obtained from Amersham International (Bucks, U.K.). Recombinant epidermal growth factor was obtained from R&D Systems (Oxon, U.K.). Polyclonal anti-Rho Ab was obtained from Autogenbioclear (Wilts, U.K.). Anti-transferin receptor mAb (MAB451) was obtained from Chemicon (London, U.K.). Mouse anti-rat ICAM-1 (1A29) was obtained azide-free from Serotec (Oxon, U.K.). The mouse mAb to p80/85 cortactin was a generous gift from J. T. Parsons (University of Virginia, Charlottesville, VA). The pGEX-2T-C3 construct was a generous gift from L. A. Fieg (Tufts University, Boston, MA). Unless otherwise stated, all chemicals used were obtained from Sigma (Dorset, U.K.).

Endothelial cells

Primary rat brain endothelium.

Cultures were isolated as previously described 24, 25 , and these methods routinely produced primary cultures of >95% purity. Briefly, rat cerebral cortex was dispersed by enzymatic digestion, microvessel fragments separated from other material and single cells by density-dependent centrifugation and plated onto collagen-coated plastic. Cultures were maintained in Ham’s F-10 medium supplemented with 17.5% plasma-derived serum (First Link, West Midlands, U.K.), 7.5 μg/ml of EC growth supplement (First Link), 80 μg/ml of heparin, 2 mM glutamine, 0.5 μg/ml of vitamin C, 100 U/ml of penicillin, and 100 μg/ml of streptomycin at 37°C in 5% CO2. Medium was replaced every 3 days.

Immortalized EC.

The immortalized Lewis rat brain EC line GP8.3 22 was maintained in Ham’s F-10 medium supplemented with 17.5% FCS, 7.5 μg/ml of EC growth supplement, 80 μg/ml of heparin, 2 mM glutamine, 0.5 μg/ml of vitamin C, 100 U/ml of penicillin, and 100 μg/ml of streptomycin. The immortalized Lewis rat brain EC line RBE4 was maintained in 1:1 Hams F-10/αMEM (Life Technologies, Paisley, U.K.) supplemented with 10% FCS (Life Technologies), as previously described 21 . Cultures were maintained at 37°C in 5% CO2, and medium was replaced every 3 days until the formation of monolayers.

Fluorescence microscopy

Actin localization.

Cells were fixed in 3.7% paraformaldehyde in PBS for 10 min, followed by 50 mM Tris-HCl (pH 7.5)/PBS for 10 min. Cells were subsequently permeabilized in 0.5% Triton X-100/PBS and incubated with 0.1 μg/ml of FITC-phalloidin for 1 h. Cells were exhaustively washed in PBS and viewed on a Leica (Milton Keynes, U.K.) confocal fluorescence microscope.

ICAM-1 localization.

For ICAM-1 localization, cells were fixed as described above and incubated with 10% normal goat serum/PBS. Cells were subsequently exposed to 1 μg/ml of anti-rat ICAM-1 (1A29) for 1 h at room temperature, exhaustively washed in PBS, and incubated with anti-mouse-FITC or anti-mouse-Cy3 (1:50; Jackson ImmunoResearch, West Grove, PA) for 1 h. Cells were exhaustively washed in PBS and viewed on a Leica confocal fluorescence microscope.

Tyrosine phosphorylation of cortactin

Cell cultures (equivalent to 1 × 105 cells) were lysed with 250 μl of SDS-PAGE buffer (10 mM Tris-HCl (pH 6.8), 4% SDS, 20% glycerol, 0.4% dithithreitol, 1 mM sodium orthovanadate, and 0.1% bromophenol blue), boiled for 10 min, and subject to 7.5% SDS-PAGE. Proteins were electrophoretically transferred to nitrocellulose membranes (Amersham) and immunoblotted using either 2.5 μg/ml of mouse anti-phosphotyrosine (Upstate Biotechnology, Lake Placid, NY) or 1 μg/ml of anti-cortactin followed by peroxidase-conjugated RAM IgG. Blots were subsequently developed using the ECL system (Amersham) and exposed to x-ray film. Immunoprecipitation of p80/85 cortactin was achieved following lysis of cells for 30 min in buffer (10 mM Tris-HCl (pH 7.5), 140 mM NaCl, 1% digitonin, 1 mM phenylmethylsulfonyl fluoride, 1 mM orthovanadate, 50 U/ml of aprotinin, 1 mM EDTA, 2 μg/ml of pepstatin, and 2 μg/ml of leupeptin), followed by removal of nuclei (13,000 × g for 30 min) and incubation with 1 μg/ml of anti-cortactin mAb for 1 h at 4°C. Cell lysates were preincubated with 50 μl of RAM-coated pansorbin (Calbiochem, Notts, U.K.) for an additional 30 min at 4°C, and immune complexes were collected by centrifugation. Immune complexes were extensively washed in lysis buffer and further analyzed by Western blot analysis. p80/85 cortactin phosphorylation was quantitated by densitometry and normalized to levels of immunoprecipitated cortactin.

Soluble (S)-Ag specific CD4+ T cell lines

Lewis rat T lymphocyte cell lines specific for purified bovine retinal S-Ag were prepared as previously described 26 . Briefly, lymph nodes were collected from bovine S-Ag immunized rats, and the T lymphocytes were propagated by periodically alternating Ag activation with IL-2 stimulation. The cell lines express the marker of the CD4+ T cell subset, are CD45Rclow, and recognize S-Ag in the molecular context of MHC class II determinants 26 . These cells have previously been shown to be highly migratory across monolayers of primary cultured brain and retinal endothelia 1, 4, 11 and represent Ag-stimulated lymphocytes.

Adhesion of peripheral lymph node cells (PLNC) to endothelia

Adhesion assays were conducted as previously described 27, 28 using cells harvested from Lewis rat peripheral lymph nodes. Briefly, PLNC were isolated, and T lymphocytes were obtained after purification on nylon wool columns. These cells that represent non-Ag-activated T lymphocytes are therefore nonmigratory but highly adhesive when activated with the mitogen Con A 1, 4, 11 . PLNC were activated for 24 h with type V Con A, washed twice in HBSS, and cells labeled with 3 μCi [51Cr] per 106 cells in HBSS for 90 min at 37°C. After washing the cells three times with HBSS, they were resuspended in RPMI 1640 medium containing 10% FCS. Endothelial monolayers grown on 96-well plates were prepared by removing the culture medium and washing the cells four times with HBSS. [51Cr]-labeled PLNC (200 μl) at a concentration of 1 × 106/ml was then added to each well and incubated at 37°C for 1.5 h. In each assay, γ emissions from each of six replicate blank wells were determined to provide a value for the total amount of radioactivity added per well and to allow calculation of the specific activity of the cells. After incubation, nonadherent cells were removed with four separate washes from the four poles of the well with 37°C HBSS as previously described 27, 29 . Adherent PLNC were lysed with 2% SDS, the lysate removed, and γ emissions quantitated by spectrometry. Results are expressed as the fractional adhesion of PLNC to untreated EC. Results were obtained from at least three independent experiments using a minimum of four separate wells per treatment. The results are expressed as the means ± SEM, and significant differences between groups were determined by Student’s t test.

T lymphocyte transendothelial migration

The ability of the immortalized cells to support the transendothelial migration of Ag-specific T lymphocytes was determined using a well-characterized assay as previously described 1, 4, 11 . Briefly, T lymphocytes were added (2 × 105 cells/well) to 24-well plates containing EC monolayers. Lymphocytes were allowed to settle and migrate over a 4-h period. To evaluate the level of migration, cocultures were placed on the stage of a phase-contrast inverted microscope housed in a temperature controlled (37°C), 5% CO2 gassed chamber (Zeiss, Herts, U.K.). A 200 × 200-μm field was randomly chosen and recorded for 10 min spanning the 4-h time point using a camera linked to a time-lapse video recorder. Recordings were replayed at 160× normal speed, and lymphocytes were identified and counted that had either adhered to the surface of the monolayer or that had migrated through the monolayer. Lymphocytes on the surface of the monolayer were identified by their highly refractive morphology (phase-bright) and rounded or partially spread appearance. In contrast, cells that had migrated through the monolayer were phase-dark, highly attenuated, and were seen to probe under the EC in a distinctive manner 1, 4, 11 . Treatment of EC with cytochalasin D or C3 transferase was conducted before addition of lymphocytes, following extensive washing and replacement into new medium. Control data were expressed as the percentage of total lymphocytes within a field that had migrated through the monolayer. All other data were expressed as a percentage of the control migrations. A minimum of three independent experiments using a minimum of wells per assay was performed. The results are expressed as the means ± SEM, and significant differences between groups are determined by Student’s t test.

Expression and purification of C3 transferase

Glutathione S-transferase-C3 was expressed in Escherichia Coli for 5 h using 1 mM isopropyl β-d-thiogalactoside (Life Technologies/BRL). Cells were harvested by centrifugation at 4000 × g for 15 min and sonicated three times for 5 min in lysis buffer (50 mM Tris-HCl (pH 8), 50 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF)). Bacterial lysates were then centrifuged at 10,000 × g for 30 min, and the supernatant was chromatographed over glutathione-agarose. The column was washed with 5 vol of AEBSF-free lysis buffer and 3 vol of thrombin cleavage buffer (50 mM Tris-HCl (pH 8), 150 mM NaCl, 5 mM MgCl2, 2.5 mM CaCl2, and 1 mM DTT). Bovine plasma thrombin (10 U/ml gel) was then added to the column for 16 h at 4°C. The eluate from the column was collected and subsequently washed with 3 vol of PBS. Thrombin was removed from C3 transferase protein released from the column by chromatography over p-aminobezamidine-agarose and dialysed into PBS. C3 transferase was then concentrated in ultrafiltration units (Amicon, Beverley, MA). This procedure produced pure C3 transferase protein as assessed by SDS-PAGE. Protein concentration was assessed using bicinchoninic acid (BCA) reagent (Pierce, Chester, U.K.).

[32P]adenosine 5′-diphosphate (ADP)-ribosylation of endothelial and lymphocyte lysates with C3 transferase

Cells were lysed in 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 2 mM MgCl2, and 1 mM AEBSF, and protein concentrations were determined using BCA reagent (Pierce). Lysate protein (25 μg) was then added to reactions containing 50 mM Tris-HCl (pH 7.4), 1 mM EDTA, 2 mM MgCl2, 0.5 mM ATP, 0.3 mM guanosine triphosphate (GTP), 1 mM AEBSF, 5 μCi/ml of [α-32P]NAD, and 250 ng/ml of recombinant C3 transferase and incubated at 37°C for 1 h. Reactions were stopped by the addition of 2 vol of 30% w/v trichloroacetic acid on ice for 30 min. Precipitated proteins were separated by centrifugation at 14,000 × g for 10 min, and pellets were washed three times with ethanol at −20°C. Pellets were dried, solubilized in 10 mM Tris-HCl (pH 6.8), 4% SDS, 20% glycerol, 0.4% dithithreitol, and 0.1% bromophenol blue, and proteins resolved on 15% SDS-PAGE.

Guanine-nucleotide, immunoprecipitation, and immunoblot analysis of endothelial Rho proteins

Serum-starved GP8.3 (5 × 106) cells were incubated in phosphate-free DMEM overnight in the presence of 0.2 mCi/ml of [32P]orthophosphate. Cells were washed in HBSS and recultured in serum-free DMEM. After addition of stimuli, cells were lysed in 100 mM HEPES (pH 7.4), 2% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 300 mM NaCl, 10 mM MgCl2, 2 mM EGTA, 2 mg/ml of BSA, and protease inhibitors (20 mM benzamidine, 20 μg/ml of leupeptin, 20 μg/ml of pepstatin, 20 μg/ml of aprotinin, 20 μg/ml of soybean trypsin inhibitor, and 2 mM AEBSF). Lysates were centrifuged at 14,000 × g for 5 min to sediment nuclei, and supernatants were adjusted to 500 mM NaCl. Lysates were immunoprecipitated by incubation with 4 μg rabbit polyclonal anti-Rho (Autogenbioclear) for 2 h at 4°C followed by incubation with 50 μl of 50% protein G-Sepharose (Pharmacia, Oxon, U.K.) for 2 h at 4°C. Immunoprecipitates were washed eight times with 1 ml of 50 mM HEPES (pH 7.4), 0.005% SDS, 500 mM NaCl, and 0.1% Triton X-100. Immunoprecipitates were subsequently heated to 68°C for 20 min in the presence of 5 mM EDTA, 2 mM DTT, 0.2% SDS, 0.5 mM GTP, and 0.5 mM guanosine diphosphate (GDP) to elute [32P]phosphate-labeled nucleotides. Nucleotides were separated by thin-layer chromatography on 0.1-mm polyethyleneimine-cellulose plates (Machery-Nagel Beds, U.K.) in 1.2 M ammonium formate/0.8 M HCl 30 and autoradiographed at −70°C using Fuji-RX film. Autoradiographs were subsequently used as templates and radioactive areas that comigrated with GTP and GDP standards, scraped, and radioactivity determined by β-scintillation spectrometry. EC lysates were also resolved on 15% SDS-PAGE gels and electrotransferred to nitrocellulose. Membranes were blocked with 10% dried milk protein for 1 h at room temperature and incubated in 0.1 μg/ml of polyclonal anti-Rho Ab (Autogenbioclear) for 1 h at room temperature. Endothelial Rho proteins were visualized following incubation with horseradish peroxidase (HRP)-conjugated goat anti-rabbit (1:15,000; Promega, Hants, U.K.) and subsequent development by ECL (Amersham). [32P]-nucleotides were normalized to levels of immunoprecipitated Rho proteins.

Protein determination

Protein concentration in cell lysates was determined using BCA reagent (Pierce) with BSA as standard.

Results

Cross-linking of endothelial ICAM-1 results in clustering of ICAM-1 and actin stress-fiber formation

Ligation of the external domain of endothelial ICAM-1 molecules with mouse anti-rat ICAM-1 (1A29; 20 μg/ml for 30 min) followed by cross-linking with RAM IgG (60 μg/ml for 15 min) led to clustering of endothelial ICAM-1 molecules and a redistribution of the endothelial actin cytoskeleton in both serum-starved RBE4 (Fig. 1⇓, c and d) and GP8.3 cells (data not shown), which had previously been incubated with 50 U/ml of IFN-γ for 48 h to increase ICAM-1 expression. In EC, under identical conditions but in the absence of ICAM-1 cross-linking, FITC-phalloidin staining showed the actin cytoskeleton to be diffuse with few stress fibers and a cortical concentration of actin in both RBE4 (Fig. 1⇓b), GP8.3 (data not shown), and primary culture cells (data not shown). ICAM-1 staining was uniformly distributed within the plasma membrane (Fig. 1⇓a). However, following ICAM-1 cross-linking for 15 min, there was a dramatic increase in the number of actin stress fibers that was not observed after treatment of cells with either RAM (Fig. 1⇓b) or anti-ICAM-1 alone (data not shown). Identical results were observed in both RBE4 and GP8.3 cells (data not shown). Exposure of RBE4 (Fig. 1⇓c and j) or GP8.3 (data not shown) cells to 10 μM lysophosphatidic acid (LPA) also resulted in a similar induction of actin stress fibers (Fig. 1⇓j). Cross-linking of the transferin receptor did not induce stress fibers in either GP8.3 or RBE4 cells and were identical to control or RAM-treated cells (data not shown). Similar effects on actin stress-fiber formation were also observed in both RBE4 and GP8.3 cells following ICAM-1 cross-linking to basal levels of ICAM-1 (data not shown).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Effect of ICAM-1 cross-linking Abs on ICAM-1 localization and actin distribution: effect of cytochalasin D and C3 transferase. RBE4 cells were preincubated for 48 h with 50 U/ml of rat IFN-γ and exposed to 20 μg/ml of mouse anti-rat ICAM-1 (1A29) for 30 min, followed by RAM (60 μg/ml) for 15 min. Cells were then subsequently fixed in 3.7% paraformaldehyde for 10 min, followed by 50 mM Tris-HCl (pH 7.5) for 10 min and stained for actin and ICAM-1 localization. Cells were either incubated with 1 μg/ml of anti-rat ICAM-1 (1A29) or permeabilized in 0.5% Triton X-100 and incubated in 0.1 μg/ml of FITC-phalloidin for 1 h. For ICAM-1 staining, cells were washed six times in phosphate buffered saline A and incubated with anti-mouse-Cy3 (1:50) for 1 h. Cells were then exhaustively washed in phosphate buffered saline A and visualized by confocal fluorescence microscopy. Cells were serum- and growth factor-deprived 48 h before addition of cross-linking Abs. Identical fields were stained for ICAM-1 and actin. a and b, RAM (60 μg/ml) only. c and d, ICAM-1 (20 μg/ml) followed by RAM (60 μg/ml). e and f, ICAM-1 (20 μg/ml) followed by RAM (60 μg/ml) in presense of 2 μM cytochalasin D. g and h, ICAM-1 (20 μg/ml) followed by RAM (60 μg/ml) following 8 h pretreatment with 50 μg/ml of C3 transferase. i and j, 10 μM LPA. a, c, e, g, and i, stained for ICAM-1. b, d, f, h, and j, stained for actin. Scale bar = 25 μm. ICAM-1 stains are shown as projections of all optical sections. A single identical optical section is shown for phalloidin staining.

Cross-linking of endothelial ICAM-1 or coculture with T lymphocytes results in GTP-loaded endothelial Rho

Serum-starved GP8.3 cells induced with 50 U/ml of IFN-γ for 48 h were labeled with 0.2 mCi/ml of [32P]-orthophosphate in phosphate-free growth medium for 20 h. Cells were washed in phosphate containing serum-free growth media and stimulated with RAM (60 μg/ml) alone, anti-ICAM-1 (20 μg/ml) followed by RAM (60 μg/ml), anti-transferin receptor (20 μg/ml) followed by RAM (60 μg/ml), or a 10:1 ratio of syngeneic peripheral node lymphocytes. Rho proteins were subsequently immunoprecipitated from cell lysates, bound nucleotides eluted, and analyzed by TLC. Analysis of GTP:GDP ratios of Rho proteins immunoprecipitated from GP8.3 EC showed that following cross-linking of EC ICAM-1 for 10 min, or coculture with T lymphocytes for 10 min (following initial settling and adhesion of T lymphocytes), there was an 8.0-fold and 9.5-fold increase in the GTP:GDP ratio, respectively, as compared with either unstimulated cells or cells treated with RAM only (Fig. 2⇓A). The increase in GTP:GDP-bound Rho was transitory following ICAM-1 cross-linking, returning to control levels at 30 min. C3 transferase pretreatment of EC showed an 85% and 77% inhibition of ICAM-stimulated and lymphocyte-stimulated Rho-GTP loading in EC, respectively. Immunoprecipitation of transferin receptor from ICAM-1/RAM-treated cells followed by GTP/GDP analysis revealed no labeled guanine nucleotides demonstrating that 32P-labeled nucleotides were derived from immunoprecipitated Rho proteins. In addition, immunoblot analysis of cell lysates demonstrated that similar amounts of EC Rho proteins were immunoprecipitated following each treatment (Fig. 2⇓B).

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

ICAM-1 cross-linking induces an increase in GTP-loaded Rho proteins. A, Serum-starved GP8.3 cells were cultured in the presence of 50 U/ml of rat IFN-γ for 48 h and in phosphate-free growth medium supplemented with 0.2 mCi/ml of [32P]orthophosphate for 20 h. Cells were washed in normal growth medium and were stimulated with either RAM (60 μg/ml) alone for 10 min, anti-ICAM-1 (20 μg/ml) for 30 min followed by RAM (60 μg/ml) for 10 min, anti-transferin receptor (20 μg/ml) followed by RAM (60 μg/ml), or a 10:1 ratio of lymphocytes. In C3 transferase experiments, cells were treated for 4 h with 50 μg/ml of C3 transferase before incubation with Abs or coculture with PLNC. Cells were lysed on ice in 0.5 ml of 100 mM HEPES (pH 7.4), 2% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 300 mM NaCl, 10 mM MgCl2, 2 mM EGTA, 2 mg/ml of BSA, and protease inhibitors. Nuclei were removed and lysates adjusted to 500 mM NaCl. Anti-Rho Ab (4 μg) (+) or anti-transferin receptor (control) (+) was added and incubated with lysates for 2 h at 4°C followed by 50 μl of 50% protein-G Sepharose. Immunoprecipitates were washed with 50 mM HEPES (pH 7.4), 0.005% SDS, 500 mM NaCl, 0.1% Triton X-100 and heated to 68°C for 20 min in the presence of 5 mM EDTA, 2 mM DTT, 0.2% SDS, 0.5 mM GTP, and 0.5 mM GDP. Labeled nucleotides were separated by TLC on polyethyleneimine-cellulose plates in 1.2 M ammonium formate/0.8 M HCl and autoradiographed. Areas containing GTP and GDP as assessed by comigration with GTP and GDP standards were scraped and radioactivity determined by β-scintillation spectrometry. +, presence of ICAM-1 mAb, RAM transferin-receptor mAb, C3 transferase, or lymphocytes. −, no mAb, C3 transferase, or lymphocytes added. Time points involving the addition of lymphocytes were taken following an initial coculture period of 30 min that was necessary to allow the majority of the T lymphocytes to settle on the EC monolayer.

Cytochalasin D inhibits ICAM-1-mediated stress-fiber formation and cortactin phosphorylation in EC

Since ICAM-1 cross-linking induced the formation of actin stress fibers in EC, the potential role of the actin cytoskeleton in regulating ICAM-1-mediated signals was assessed. Therefore, ICAM-1 was cross-linked on RBE4 EC as described above in the presence of 2 μM cytochalasin D or vehicle (0.5% DMSO). p80/85 cortactin was immunoprecipitated from EC lysates obtained from either control or treated cells. Immunoprecipitated proteins were resolved on 7.5% SDS-PAGE and immunoblotted with anti-phosphotyrosine Ab. p80/85 cortactin 20 showed a 2.7-fold increase in tyrosine phosphorylation following cross-linking of ICAM-1, which was abolished (inhibited by 100%) in the presence of 2 μM cytochalasin D (Fig. 3⇓). Reprobing of immunoblots with mouse anti-cortactin mAb revealed that equal amounts of p85 cortactin were immunoprecipitated following each treatment. Treatment of RBE4 cells with 2 μM cytochalasin D for 1 h resulted in the disruption of all polymerized actin that exhibited a punctate distribution (Fig. 1⇑f). Under these conditions, cross-linking ICAM-1 Abs were unable to induce the appearance of actin stress fibers. Pretreatment of EC with cytochalasin D also appeared to alter the cellular localization of ICAM-1 (Fig. 1⇑e).

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Effect of cytochalasin D on ICAM-1-stimulated cortactin phosphorylation. Serum-starved RBE4 cells cultured in the presence of 50 U/ml of rat IFN-γ for 48 h were stimulated with either RAM (60 μg/ml) alone (−) or anti-ICAM-1 (20 μg/ml), followed by RAM (60 μg/ml) (+) in the presence of 2 μM cytochalasin D (in 0.5% DMSO) or vehicle (DMSO alone). Cells were lysed and immunoprecipitated with anti-cortactin Ab, and immunoprecipitates were resolved on 7.5% SDS-PAGE. Proteins were transferred to nitrocellulose and immunoblotted with anti-phosphotyrosine Ab (A), followed by stripping and reprobing with anti-cortactin Ab (B). Immunoblots were exposed to anti-mouse HRP-conjugated secondary Ab and developed using ECL.

ICAM-1-stimulated stress-fiber formation, but not cortactin phosphorylation, is inhibited by pretreatment of EC with C3 transferase

In a variety of other cell types, the regulation of actin stress fibers is regulated by members of the Rho family of small GTP-binding proteins 31 . Therefore, to assess the potential role of these proteins in ICAM-1-mediated signaling, EC were treated with the bacterial toxin C3 transferase, which is capable of entering cells and inactivating Rho proteins. Treatment of EC with 50 μg/ml of C3 transferase followed by in vitro ribosylation of EC lysates with C3 transferase and [α-32P]NAD showed a time-dependent inactivation of EC Rho proteins (Fig. 4⇓). Inactivation of EC Rho proteins is apparent as a reduction in the availability of substrate for subsequent in vitro [α-32P]ADP ribosylation in EC lysates. Only one major C3 transferase substrate was observed in EC or lymphocyte lysates with an apparent m.w. of ∼25 kDa, which is consistent with Rho proteins that have been correctly posttranslationally modified 32 . C3 transferase treatment of both RBE4 (Fig. 1⇑h) and GP8.3 cells (data not shown) significantly reduced the number of actin stress fibers and abolished the induction of stress-fiber formation following subsequent ICAM-1 cross-linking. In a similar manner to cytochalasin D, C3 transferase also resulted in a redistibution of EC ICAM-1 (Fig. 1⇑g). Immunoprecipitation and Western blot analysis demonstrated that preincubation of either RBE4 (Fig. 4⇓) or GP8.3 (data not shown) EC for 8 h with 50 μg/ml of C3 transferase, under which conditions all EC Rho protein was inactivated, was ineffective in inhibiting the ICAM-1-mediated enhanced tyrosine phosphorylation of p80/85 cortactin (Fig. 5⇓). Cross-linking of RBE4 cells with ICAM-1/RAM led to a 3.7-fold increase in tyrosine phosphorylated cortactin, which compared with a 3.6-fold induction following preincubation with C3 transferase.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Time course of C3-mediated ADP ribosylation of Rho proteins in EC and lymphocytes. Confluent cultures of EC were pretreated for specified times (0–8 h) with 50 μg/ml of recombinant C3 transferase. In separate experiments, GP8.3 cells, RBE4 cells, or lymphocytes cocultured with C3-treated GP8.3 EC were washed, lysed, and ADP ribosylated with 250 ng/ml of C3 transferase in the presence of 5 μCi/ml of [α-32P]NAD, 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 2 mM MgCl2, 1 mM AEBSF, 300 μM GTP, and 0.5 mM ATP. Lysate proteins were then resolved on 15% SDS-PAGE and autoradiographed.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Effect of C3 transferase on ICAM-1-stimulated cortactin phosphorylation. RBE4 cells cultured in the presence of 50 U/ml of IFN-γ for 48 h and serum-starved for 24 h were stimulated with either RAM alone or anti-ICAM-1 (20 μg/ml), followed by RAM (60 μg/ml) (+) in either untreated cells or cells previously treated with 50 μg/ml of recombinant C3 transferase for 8 h. Cells were lysed and immunoprecipitated with anti-cortactin Ab, and immunoprecipitates were resolved on 7.5% SDS-PAGE. Proteins were transferred to nitrocellulose and immunoblotted with anti-phosphotyrosine Ab (A), followed by stripping and reprobing with anti-cortactin Ab (B). Immunoblots were exposed to anti-mouse HRP-conjugated secondary Ab and developed using ECL.

Cytochalasin D inhibits lymphocyte migration through, but not adhesion to, EC monolayers

Rat brain EC monolayers were able to support the ICAM-1-dependent transendothelial migration of Ag-specific lymphocytes over a 4-h period with 43 ± 5.5% (n = 22) of the lymphocytes migrating through the EC monolayer. The ICAM-1-dependency of Ag-specific T cell migration through CNS EC has previously been demonstrated in Ab blockade studies 1, 11 . Pretreatment of GP8.3 monolayers with 2 μM cytochalasin D for 1 h followed by removal, exhaustive washing, and replacement with fresh medium before coculture with lymphocytes dramatically reduced transendothelial migration of Ag-specific lymphocytes to 61.8 ± 14.3% (p < 0.0001; n = 6) of the control value (Fig. 6⇓A). Increasing the pretreatment time of GP8.3 monolayers with 2 μM cytochalasin D to either 3 h or 24 h brought about a further decrease in migration to 39.7 ± 12.3.% and 35.8 ± 14.8% of control values, respectively. Similar results were obtained from identical experiments using both primary cultures (data not shown) and RBE4 cells (data not shown). Increased pretreatment times of EC with cytochalasin D were found to be necessary since cytochalasin D was not present during the 4-h lymphocyte coculture, and the effects of cytochalasin D treatment on EC stress-fiber formation was observed to be partially reversible under these conditions. Basal adhesion of Con A-stimulated PLNC, which adhere in an identical manner to Ag-specific T cell lines, but are not capable of transendothelial migration, 4 to GP8.3 EC was 18.0 ± 0.7%. Basal adhesion of PLNC to primary cultures and RBE4 cells was similar to that observed for GP8.3. Pretreatment of EC with either 2–20 μM cytochalasin D did not affect the adhesion of PLNC to GP8.3 (Fig. 6⇓B), RBE4, or primary cultures of EC (data not shown). These findings demonstrate that the effects of cytochalasin D in inhibiting lymphocyte migration is due to an effect on the endothelial support of lymphocyte migration and not to prevention of lymphocyte binding to endothelia. In addition, it was also observed that treatment of EC with cytochalasin D did not affect the adhesion of cocultured Ag-specific lymphocytes since, during time-lapse video microscopy, lymphocytes displayed normal spreading and motile behavior on the EC surface. All EC monolayers used were able to exclude trypan blue following pretreatment with cytochalasin D and coculture with lymphocytes.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Effect of cytochalasin D on lymphocyte adhesion to and migration through brain endothelial monolayers. GP8.3 cells were treated with either vehicle (0.5% DMSO) or 2 μM cytochalasin D for various times. After removal and vigorous washing, 51Cr-labeled Con A-activated (5 μg/ml) rat PLNC (adhesion) or Ag-specific T cells (migration) were added and allowed to adhere for 90 min or migrate over a 4-h period, respectively. A, Migration of Ag-specific lymphocytes through GP8.3 cells. B, Adhesion of Con A-stimulated PLNC to GP8.3 cells. Observations are a minimum of three independent experiments using a minimum of four wells per assay. Data is expressed as mean ± SEM percent of control migration. Significant differences between groups were determined by Student’s t test. ∗, p < 0.02. Identical data was also obtained with both primary cultures and RBE4 cells.

Transendothelial lymphocyte migration but not adhesion is inhibited by pretreatment of EC with C3 transferase

Pretreatment of both GP8.3 and RBE4 EC with 50 μg/ml of C3 transferase resulted in the inhibition of transendothelial lymphocyte migration (Fig. 7⇓, A and B). Lymphocyte migration through monolayers of GP8.3 cells after incubation with C3 transferase for 4 h and 8 h was reduced to 60.1 ± 4.2% (p < 0.005) and 18.4 ± 4.1% (p < 0.005) of control values, respectively. Lymphocyte migration across cultures of RBE4 cells was only significantly inhibited after preincubation with C3 transferase for 12 h before coculture with lymphocytes, which resulted in a reduction to 23.4 ± 4.6% (p < 0.0001) of control lymphocyte migration. The time of C3 transferase incubation necessary for significant inhibition of lymphocyte migration corresponded to total inactivation of RBE4 cell Rho protein as assessed by in vitro ADP ribosylation (Fig. 4⇑).

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

Effect of C3 transferase on lymphocyte adhesion to and migration through EC monolayers. Endothelial monolayers were pretreated with 50 μg/ml of recombinant C3 transferase for specified times between 0–12 h. After removal and vigorous washing, 51Cr-labeled Con A-activated (5 μg/ml) rat PLNC (adhesion) or Ag-specific T cells (migration) were added and allowed to adhere for 90 min or migrate over a 4-h period, respectively. A, Migration of Ag-specific lymphocytes through GP8.3 cells. B, Migration of Ag-specific lymphocytes through RBE4 cells. C, Adhesion of Con A-stimulated PLNC to GP8.3 cells. D, Adhesion of Con A-stimulated PLNC to RBE4 cells. Observations are a minimum of three independent experiments using a minimum of four wells per assay. Data is expressed as mean ± SEM percent of control migration. Significant differences between groups were determined by Student’s t test. ∗, p < 0.02.

ADP ribosylation of lymphocyte lysates obtained from cells previously cocultured for 4 h with C3 treated EC showed no inactivation of lymphocyte Rho proteins (Fig. 4⇑). The ability of lymphocytes to migrate across untreated endothelial monolayers was also not affected by their pre-exposure to C3-treated EC, since lymphocytes that had previously been cocultured with C3-treated endothelial monolayers were found to migrate normally when subsequently cocultured with untreated EC (data not shown). The binding of Con A-activated PLNC to GP8.3 or RBE4 cells was unaffected by preincubation of EC with 50 μg/ml of C3 transferase for up to 24 h (Fig. 7⇑, C and D). In addition, treatments that are known to activate Rho function, such as exposure of cells to LPA (10 μM) 31 or epidermal growth factor (100 nM), which is capable of up-regulating RhoB mRNA in GP8.3 cells (P.A. and J.G., unpublished observations) and rat fibroblasts 33 , did not affect the extent of lymphocyte/EC adhesion in either GP8.3 or RBE4 cells (Fig. 7⇑, C and D). Ag-specific lymphocytes cocultured with C3 transferase-treated EC displayed normal surface spreading and motility on the EC surface. C3 treatment of EC had no affect on the integrity of the EC monolayer, and the EC retained their ability to exclude trypan blue. Con A-stimulated PLNC were used in adhesion assays to demonstrate that the effects of both cytochalasin D and C3 transferase were due to effects on EC mechanisms responsible for facilitating T lymphocyte migration, and not due to inhibition of lymphocyte binding to EC. Con A-stimulated PLNC and Ag-specific T lymphocytes have the same adhesive capacity, but PLNC do not have the ability to migrate due to the absence of Ag and IL-2 stimulation 1 . This approach allows independent assessment of factors affecting the separate steps of adhesion and migration. Using time-lapse video microscopy, no differences were observed in the adhesion of Ag-specific T lymphocytes to EC following treatment of cells with either cytochalasin D or C3 transferase (data not shown)

Discussion

The activation state of a circulating T lymphocyte is of paramount importance in determining its ability to migrate out of the circulation 2, 3, 4, 7 . Nevertheless, using functional assays, our studies have shown for the first time that brain EC are intimately and actively involved in facilitating lymphocyte diapedesis. It has previously been demonstrated that the expression of the adhesion molecule ICAM-1 on EC is pivotal in supporting lymphocyte migration across vascular endothelium 1, 3, 7, 11 . To date, its role in this process has been generally interpreted as the provision of an extracellular docking molecule for leukocyte attachment and locomotion via ligation with receptor LFA-1. However, despite a lack of direct evidence, it has been proposed that the efficient transvascular migration of lymphocytes require intracellular signals to be generated within the EC. This paper demonstrates that the migration of lymphocytes through CNS vascular barriers can only proceed through the active involvement of intracellular processes within the EC, in addition to those elicited within the lymphocyte following Ag stimulation. In support of this thesis, we have recently shown that brain EC ICAM-1 is capable of eliciting signal transduction events following ICAM-1 cross-linking or coculture with T lymphocytes, demonstrating that EC actively respond to leukocyte adhesion 20 . Mimicking lymphocyte attachment through cross-linking EC ICAM-1 molecules in vitro, we have confirmed in both GP8.3 and RBE4 rat brain EC lines that there is an enhanced tyrosine phosphorylation of cortactin 20 , FAK, paxillin, and p130cas 23 . Following ligation of EC ICAM-1, which was up-regulated by prior exposure to IFN-γ, there is a reorganization of the EC actin cytoskeleton that results in stress-fiber formation. However, similar effects were also observed following ligation to basal ICAM-1 expressed on EC, suggesting that pretreatment of cells with IFN-γ was not involved in ICAM-1-induced signals. Pretreatment of EC with cytochalasin D inhibited both ICAM-1-stimulated cortactin phosphorylation and lymphocyte transendothelial migration, which supports the proposal that the endothelial actin cytoskeleton plays a vital role in orchestrating these events.

The observation that both ICAM-1 cross-linking and coculture of EC with Con A-stimulated PLNC results in increased levels of GTP-loaded endothelial Rho proteins strongly suggests that endothelial Rho proteins are involved in ICAM-1-mediated signaling events. As previously reported 34 , Rho itself may be activated through cell-surface signals propagated through the actin cytoskeleton. In support of this, pretreatment of EC with C3 transferase, which is able to specifically ADP ribosylate 35 and inhibit Rho proteins, resulted in a substantial inhibition of transendothelial lymphocyte migration, inhibition of both ICAM-1 and lymphocyte-stimulated Rho-GTP loading, and inhibition of ICAM-1-stimulated stress-fiber formation, but was unable to inhibit ICAM-1-stimulated cortactin phosphorylation. Other studies from these laboratories have also demonstrated that ICAM-1-induced increases in the tyrosine phosphorylation of FAK, paxillin, and p130cas and increases in the activity of Jun-kinase, are all effectively inhibited following pretreatment of GP8.3 and RBE4 cells with C3 transferase 23 . Treatment of EC monolayers with 50 μg/ml of recombinant C3 transferase for up to 8 h resulted in the complete inactivation of EC Rho proteins, as assessed by the inability of C3 transferase to incorporate [α-32P]ADP-ribose into lysates of EC monolayers previously exposed to C3 transferase in culture (Fig. 4⇑). It was also observed that the inactivation of Rho proteins with C3 transferase was more rapid in GP8.3 cells than in RBE4 cells, which may reflect either a reduced uptake of C3 transferase into RBE4 cells or, as suggested in Fig. 4⇑, increased levels of C3 transferase substrate. The reduced efficiency of C3 transferase in ribosylating Rho proteins in RBE4 cells, compared with GP8.3 cells, correlated with the reduced effectiveness of C3 transferase in inhibiting transendothelial lymphocyte migration through monolayers of RBE4 cells. These studies have also demonstrated that the reduction in the ability of lymphocytes to migrate through EC monolayers is not due to C3-mediated inactivation of lymphocyte Rho proteins, since cells cocultured with C3-treated EC monolayers are able to migrate normally when transferred to untreated EC monolayers (data not shown). In addition, previous studies have shown that pretreatment of leukocytes with C3 transferase prevents their adhesion to vascular endothelia 36 , which was not observed following treatment of EC with C3 transferase. Taken together, these data suggest the effect of C3 transferase treatment is mediated through inactivation of EC Rho proteins.

The inability of C3 transferase to inhibit tyrosine phosphorylation of cortactin, which is effectively inhibited following pretreatment of cells with cytochalasin D, suggests that the role of both the actin cytoskeleton and cortactin phosphorylation may be upstream of endothelial Rho proteins. Thus, it would appear that ICAM-1-mediated signals within EC are propagated via the actin cytoskeleton, which results in the subsequent activation of Rho proteins. This scheme has previously been suggested in studies on fibroblasts, in which constitutively activated Rho, when introduced directly into cells, was able to restore Rho mediated focal adhesions in the presence of cytochalasin D 33 . Recent studies have demonstrated that tyrosine phosphorylation of cortactin, which we have shown to be phosphorylated by p60src 20 , is responsible for an increase in organized actin 37 . The observation that increased cortactin phosphorylation following ICAM-1 cross-linking is insensitive to pretreatment of EC with C3 transferase implies that cortactin may be intimately associated with the propagation of ICAM-1-induced signals within EC, which results in the subsequent activation of Rho proteins and is therefore upstream of Rho activation. Alternatively, tyrosine phosphorylation of cortactin may lie on an independent ICAM-1-stimulated pathway.

The ability of Con A-stimulated PLNC to stimulate endothelial Rho-GTP loading also demonstrates that the transduction of signaling events within the EC is not dependent on the ability of the lymphocytes to migrate through the EC monolayer and is therefore likely to occur through cell-cell adhesion. As previously suggested, the ability of T lymphocytes to migrate through EC monolayers therefore resides in an ability to effectively signal to EC coupled with signal transduction events elicited within T lymphocytes via Ag stimulation 1 . The finding that preincubation of T lymphocytes with anti-LFA-1 Abs is able to effectively inhibit both T lymphocyte adhesion and transendothelial migration 11 also supports the view that signals induced following coculture of T cells with EC are mediated through endothelial ICAM molecules.

The physiological mechanisms within EC that allow lymphocytes to migrate through the physical barrier afforded by CNS EC, and that lead to either pore formation or disaggregation of tight junctions, remains unresolved. However, in polarized epithelial cells, RhoA has been shown to be present in the cytosol of Madin Darby canine kidney (MDCK) cells where cell-cell contacts are disrupted, but translocate to cell margins when cell-cell contacts are restored 38 . In addition, Rho has been reported to regulate both perijunctional actin organization and tight junctions in both T84 and Caco2 epithelial cells 39 . Alternatively, Rho proteins have been shown to regulate cell membrane invaginations in Xenopus oocytes 40 . A similar role for Rho proteins in regulating junctional organization or pore formation within CNS EC may therefore provide a mechanism by which lymphocytes are able to penetrate the tight vascular barriers of the CNS. In conclusion, we propose that T lymphocyte diapedesis through CNS microvessels is actively facilitated by mechanisms involving adhesion-dependent signaling within the endothelium by a process that requires an intact endothelial actin cytoskeleton and functional endothelial Rho proteins.

Acknowledgments

We thank L. Fieg for the pGEX-2T-C3 construct, J. T. Parsons for anti-cortactin mAb, and O. Durieu-Trautmann for her contribution to the initial phase of this study.

Footnotes

  • ↵1 This work was supported by the Wellcome Trust (U.K.), Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Association pour le Developpment de la Recherche sur le Cancer, Ligue Nationale Francaise contre le Cancer, Université de Paris, and the Ministere de la Recherche et de l’Enseignement Superieur.

  • ↵2 Address correspondence and reprint requests to Dr. Peter Adamson, Department of Clinical Ophthalmology, Institute of Ophthalmology, University College London, Bath Street, London, EC1V 9EL, U.K. E-mail address: padamson{at}hgmp.mrc.ac.uk

  • ↵3 Abbreviations used in this paper: EC, endothelial cell(s); CNS, central nervous system; FAK, focal adhesion kinase; PLNC, peripheral lymph node lymphocytes; RAM, rabbit anti-mouse; LPA, lysophosphatidic acid; GTP, guanosine triphosphate; GDP, guanosine diphosphate; ECL, enhanced chemiluminescence; BCA, bicinchoninic acid; AEBSF, 4-(2-aminoethyl) benzenesulfonyl fluoride; ADP, [32P]adenosine 5′-diphosphate; HRP, horseradish peroxidase; NAD, nicotinamide adenine dinucleotide.

  • Received September 8, 1998.
  • Accepted November 23, 1998.
  • Copyright © 1999 by The American Association of Immunologists

References

  1. ↵
    Pryce, G., D. K. Male, I. Campbell, J. Greenwood. 1997. Factors controlling T-cell migration across rat cerebral endothelium in vitro. J. Neuroimmunol. 75: 84
    OpenUrlCrossRefPubMed
  2. ↵
    Hickey, W. F., B. L. Hsu, H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28: 254
    OpenUrlCrossRefPubMed
  3. ↵
    Oppenheimer-Marks, N., L. S. Davis, P. E. Lipsky. 1990. Human T-lymphocyte adhesion to endothelial cells and transendothelial cell migration: alteration of receptor use relates to the activation status of both the T-cell and the endothelial cell. J. Immunol. 145: 140
    OpenUrlAbstract
  4. ↵
    Greenwood, J., V. Calder. 1993. Lymphocyte migration through cultured endothelial cell monolayers derived from the blood-retinal barrier. Immunology 80: 401
    OpenUrlPubMed
  5. ↵
    Osborn, L.. 1990. Leukocyte adhesion to endothelium in inflammation. Cell 62: 3
    OpenUrlCrossRefPubMed
  6. ↵
    Springer, T. A.. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301
    OpenUrlCrossRefPubMed
  7. ↵
    Oppenheimer-Marks, N., L. S. Davis, D. T. Bogue, J. Ramberg, P. E. Lipsky. 1991. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol. 147: 2913
    OpenUrlAbstract
  8. ↵
    Kavanaugh, A. F., E. Lightfoot, P. E. Lipsky, N. Oppenheimer-Marks. 1991. Role of CD11/CD18 in adhesion and transendothelial migration of T cells. J. Immunol. 146: 4149
    OpenUrlAbstract
  9. ↵
    Yednock, T, C. A., I. C. Cannon, F. Fritz, L. Sanchez-Madrid, L. Steinman, N. Karin. 1992. Prevention of experimental autoimmune encephalitis by antibodies against α4β1 integrin. Nature 356: 63
    OpenUrlCrossRefPubMed
  10. ↵
    Male, D., J. Rahman, G. Pryce, T. Tamatani, M. Miyasaka. 1994. Lymphocyte migration into the CNS modeled in vitro: roles of LFA-1, ICAM-1 and VLA-4. Immunology 81: 366
    OpenUrlPubMed
  11. ↵
    Greenwood, J., Y. Wang, V. Calder. 1995. Lymphocyte adhesion and transendothelial migration in the CNS: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunology 86: 408
    OpenUrlPubMed
  12. ↵
    Veillette, A., M. A. Bookman, E. M. Horak, J. B. Bolan. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine protein kinase p56lck. Cell 55: 301
    OpenUrlCrossRefPubMed
  13. ↵
    Liao, F., H. S. Shin, S. G. Rhee. 1992. Tyrosine phosphorylation of phospholipase C-γ 1 induced by cross-linking the high affinity or low affinity Fc receptor for IgG in U937 cells. Proc. Natl. Acad. Sci. USA 89: 3659
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Doherty, P., F. S. Walsh. 1992. Cell adhesion molecules, second messengers and axonal growth. Curr. Opin. Neurobiol. 2: 595
    OpenUrlCrossRefPubMed
  15. ↵
    Rothlein, R., T. K. Kishimoto, E. Mainolfi. 1994. Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes. J. Immunol. 152: 2488
    OpenUrlAbstract
  16. ↵
    Chintana, C., S. A. Tibbetts, M. A. Chan, S. H. Benedict. 1995. Cross-linking of ICAM-1 on T-cells induces transient tyrosine phosphorylation and inactivation of cdc2 kinase. J. Immunol. 155: 5479
    OpenUrlAbstract/FREE Full Text
  17. ↵
    van Horssen, M., S. Loman, G. T. Rijkers, S. E. Bloom, A. C. Bloem. 1995. Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B-cell receptor signaling. Eur. J. Immunol. 25: 154
    OpenUrlCrossRefPubMed
  18. ↵
    Jackson, D. E., C. M. Ward, R. Wang, P. J. Mewman. 1997. The protein tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. J. Biol. Chem. 272: 6986
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Ricard, I., M. D. Payet, G. Dupuis. 1997. Clustering the adhesion molecules VLA-4 (CD49d)/(CD29) in Jurkat T-cells or VCAM-1 (CD106) in endothelial cells (ECV304) activates the phosphoinositide pathway and triggers Ca2+ mobilization. Eur. J. Immunol. 27: 1530
    OpenUrlCrossRefPubMed
  20. ↵
    Durieu-Trautmann, O., N. Chaverot, S. Cazaubon, A. D. Strosberg, P-O. Couraud. 1994. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J. Biol. Chem. 269: 12536
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Roux, F., O. Durieu-Trautmann, N. Foignant-Chaverot, M. Claire, P. Mailly, J. M. Bourre, A. D. Strosberg, P-O. Couraud. 1994. Regulation of γ-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J. Cell. Physiol. 159: 101
    OpenUrlCrossRefPubMed
  22. ↵
    Greenwood, J., G. Pryce, L. Devine, D. K. Male, W. L. C. dos Santos, V. L. Calder, P. Adamson. 1996. SV40 large T immortalized cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics. J. Neuroimmunol. 71: 51
    OpenUrlCrossRefPubMed
  23. ↵
    Etienne, S., P. Adamson, J. Greenwood, A. D. Strosberg, S. Cazaubon, P-O. Couraud. 1998. Rho-dependent signaling pathways coupled to ICAM-1 in microvascular brain endothelial cells. J. Immunol. 161: 5755
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Abbott, N. J., C. C. W. Hughes, P. A. Revest, J. Greenwood. 1992. Development and characterization of a rat brain capillary endothelial cell culture: towards an in vitro blood-brain barrier. J. Cell Sci. 103: 23
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Greenwood, J.. 1992. Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium. J. Neuroimmunol. 39: 123
    OpenUrlCrossRefPubMed
  26. ↵
    Zhao, Z-S., V. L. Calder, M. McLauchlan, S. L. Lightman. 1994. Differential lymphokine expression by rat antigen-specific CD4+ T cell lines with antigen and mitogen. Cell. Immunol. 159: 220
    OpenUrlCrossRefPubMed
  27. ↵
    Hughes, C. C. W., D. K. Male, P. L. Lantos. 1988. Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-γ, tumor necrosis factor and interleukin-1. Immunology 64: 677
    OpenUrlPubMed
  28. ↵
    Male, D., G. Pryce, C. Hughes, P. Lantos. 1990. Lymphocyte migration into brain modeled in vitro: control by lymphocyte activation, cytokines, and antigen. Cell. Immunol. 127: 1
    OpenUrlCrossRefPubMed
  29. ↵
    Wang, Y., V. Calder, J. Greenwood, S. Lightman. 1993. Lymphocyte adhesion to cultured endothelial cells of the blood-retinal barrier. J. Neuroimmunol. 48: 161
    OpenUrlCrossRefPubMed
  30. ↵
    Downward, J., J. D. Graved, P. H. Warne, S. Rayter, D. A. Cantrell. 1990. Stimulation of p21ras upon T-cell activation. Nature 346: 719
    OpenUrlCrossRefPubMed
  31. ↵
    Ridley, A. J., A. Hall. 1992. The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389
    OpenUrlCrossRefPubMed
  32. ↵
    Adamson, P., C. J. Marshall, A. Hall, P. A. Tilbrook. 1992. Post-translational modifications of the p21rho proteins. J. Biol. Chem. 267: 20033
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Jahner, D., T. Hunter. 1991. The ras related gene rhoB is an immediate early gene inducible by v-fps, epidermal growth factor and platelet derived growth factor in rat fibroblasts. Mol. Cell. Biol. 11: 3682
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Nobes, C. D., A. Hall. 1995. Rho, rac and cdc42 regulate the assembly of multi-molecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell 81: 53
    OpenUrlCrossRefPubMed
  35. ↵
    Aktories, K., S. Braun, S. Rosener, I. Just, A. Hall. 1989. The rho gene product expressed in E. Coli is a substrate for botulinum ADP-ribosyltransferase C3. Biochem. Biophys. Res. Commun. 158: 209
    OpenUrlCrossRefPubMed
  36. ↵
    Laudanna, C., J. J. Campbell, E. C. Butcher. 1996. The role of rho in chemoattractant-activated leukocyte adhesion through integrins. Science 271: 981
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Huang, C., Y. Ni, T. Wang, Y. Gao, G. C. Haudenschild, X. Zhan. 1997. Down regulation of the filamentous actin cross-linking activity of cortactin by c-src mediated tyrosine phosphorylation. J. Biol. Chem. 272: 13911
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Takaishi, K., T. Sasaki, T. Kameyama, S. Tsukita, S. Tsukita, Y. Takai. 1995. Translocation of activated rho from the cytoplasm to membrane ruffling area, cell-cell adhesion sites and cleavage furrows. Oncogene 11: 39
    OpenUrlPubMed
  39. ↵
    Nusrat, A., M. Giry, J. R. Turner, S. P. Colgan, C.A. Parkos, D. Carnes, E. Lemichez, P. Boquet, J. L. Madara. 1995. Rho protein regulates tight junctions and peripheral actin organization in polarized epithelia. Proc. Natl. Acad. Sci. USA 92: 10629
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Schmalzing, G., H. P. Richter, A. Hansen, W. Schwartz, I. Just, K. Aktories. 1995. Involvement of the GTP-binding protein rho in constitutive endocytosis in Xenopus laevia oocytes. J. Cell. Biol. 130: 1319
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

The Journal of Immunology: 162 (5)
The Journal of Immunology
Vol. 162, Issue 5
1 Mar 1999
  • Table of Contents
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lymphocyte Migration Through Brain Endothelial Cell Monolayers Involves Signaling Through Endothelial ICAM-1 Via a Rho-Dependent Pathway
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lymphocyte Migration Through Brain Endothelial Cell Monolayers Involves Signaling Through Endothelial ICAM-1 Via a Rho-Dependent Pathway
Peter Adamson, Sandrine Etienne, Pierre-Olivier Couraud, Virginia Calder, John Greenwood
The Journal of Immunology March 1, 1999, 162 (5) 2964-2973;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Lymphocyte Migration Through Brain Endothelial Cell Monolayers Involves Signaling Through Endothelial ICAM-1 Via a Rho-Dependent Pathway
Peter Adamson, Sandrine Etienne, Pierre-Olivier Couraud, Virginia Calder, John Greenwood
The Journal of Immunology March 1, 1999, 162 (5) 2964-2973;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CD11b+/Gr-1int monocytic myeloid derived suppressor cells contribute to high-fat induced inflammation and delayed tolerance in mouse liver (54.15)
  • Antigen presentation by dendritic cells in the aortic wall triggers T helper immune responses in atherosclerosis (54.16)
  • Eph receptors are involved in the pro-inflammatory response following spinal cord injury (54.21)
Show more Inflammation

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606